Helius boss tells global audience NZ firms are undervalued given growth potential by Martin Lane July 4, 2023April 30, 2024 Cannabis companies around the world are being valued more realistically since the Covid-19 pandemic, with New […]
Helius granted full GMP certification by NZ Ministry of Health by Martin Lane April 11, 2023April 30, 2024
New Zealand-grown cannabis medicine approved by regulator by Martin Lane September 15, 2022April 29, 2024
Company news: Helius Therapeutics; Greenfern Industries; Tilray; Creso Pharma; Live Verdure by Martin Lane September 1, 2022April 29, 2024
New Zealand’s medicinal cannabis sector deserves celebration not criticism by Carmen Doran July 6, 2022April 29, 2024
New Zealand patient enquiries driving GP interest in medicinal cannabis by Martin Lane June 21, 2022April 29, 2024
Company news: Helius; Greenfern Industries; Zelira; Creso Pharma; Emyria; Roto-Gro International by Martin Lane June 2, 2022April 29, 2024
Australian industry warned ‘NZ better placed for long-term success’ by Martin Lane June 1, 2022April 29, 2024
